FDA Label for Femadrine

View Indications, Usage & Precautions

Femadrine Product Label

The following document was submitted to the FDA by the labeler of this product Afassco Inc.. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

Otc - Active Ingredient



Acetaminophen 325mg

Pamabrom 25mg


Otc - Purpose



Pain reliever, Diuretic


Indications & Usage



Uses: For the relief of:

• cramps • bloating • water-weight gain

• headaches • backaches • muscular aches and pains


Warnings



Warnings:

Liver Warning: This product contains acetaminophen. Severe liver damage may occur if you take: • more than 8 tablets in 24 hours

• with any other drugs containing acetaminophen (prescription or non-prescription).

• 3 or more alcoholic drinks a while using this product.


Otc - Ask Doctor/Pharmacist



Ask a doctor or pharmacist before use if you are taking the blood thinning drug warfarin.


Otc - Keep Out Of Reach Of Children



Keep out of reach of children.


Otc - Pregnancy Or Breast Feeding



If pregnant or breast-feeding, ask a health professional before use.


Overdosage



In case of overdose, get medical help or contact a Poison Control Center right away. Prompt medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.


Dosage & Administration



Directions: Do not use more than directed.

Adults and children: (12 years and older) Take 2 tablets with water. Repeat every 4 hours, as needed, not to exceed 8 tablets in any 24 hour period.

Children under 12 years of age: Consult a doctor.


Inactive Ingredient



SEE ORIGINAL BOX FOR COMPLETE PRODUCT INFORMATION


Package Label.Principal Display Panel




* Please review the disclaimer below.